Home › Multiple Chronic Conditions › NCT07167927
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis - Aims 2 and 3
Who can join
Ages 8 and older · All sexes
Full eligibility criteria
Inclusion criteria: * Parent-child dyads of children with neuromuscular scoliosis who speak English and Spanish. * Child is between ages 8-21 years of age and they are coming into the pediatric orthopaedic surgery clinic for consultation about potential surgery for NMS. * NMS is defined as having neurologic impairment (NI) and scoliosis using relevant ICD-9 or ICD-10 codes from Feudtner, et al. 2014 or Berry, et al. 2012. or a qualifying diagnosis per the Pediatric Spine Study Group definition of NMS. * All pediatric orthopaedic surgeons and neurosurgeons who treat neuromuscular scoliosis at our study sites will be eligible participants. Exclusion criteria: * Families whose child with NMS is less than 8 years of age at time of orthopaedic consultation because surgery at a younger age usually indicates an atypical case. * Children with the diagnosis of Becker's muscular dystrophy due to potential disease modifying therapies that may alter curve progression.
About the study
The goal of this pilot hybrid type I efficacy/implementation trial is to assess a newly developed decision support tool patients, parents, and providers to use during surgical treatment decision making for neuromuscular scoliosis (NMS). Results from this pilot will inform the design of a future larger effectiveness trial of the decision support tool.
Participants will either receive usual care or receive the decision support tool. Researchers will assess the decision made, decision quality, individual affective, cognitive, and behavioral effects, and feasibility and acceptability of tool use. They will also collect potential barriers and facilitators to implementation and feedback about the tool and study design to maximize likelihood of successful deployment of the tool into clinical practice and inform the design of a future trial. The outcomes measures will be used to inform potential effect size estimates to inform a future trial.
What is being tested
- Decision support tool (behavioral)
Sponsor: University of Utah · Participants: 110 · Started: Oct 21, 2025
Contact the study team
- Angela Zhu, BS · Phone: 801-662-3675
- Michelle Wilcox · Phone: 801-581-6410
Official record on ClinicalTrials.gov — NCT07167927
Locations in the U.S.
| California | Children's Hospital Los Angeles, Los Angeles |
| Utah | University of Utah, Salt Lake City |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.